F · Healthcare

CONTEXT THERAPEUT.DL-001 (6K9)

Biotechnology

CONTEXT THERAPEUT.DL-001 (6K9) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 6K9

P/E ratio

25.00

CONTEXT THERAPEUT.DL-001 (6K9) — FAQ

What is 6K9's P/E ratio?

The price-to-earnings (P/E) ratio for CONTEXT THERAPEUT.DL-001 (6K9) is 25.00 (data as of 2026-05-23).

Does CONTEXT THERAPEUT.DL-001 pay a dividend?

Dividend yield is not available in the current snapshot for CONTEXT THERAPEUT.DL-001 (6K9). Check the MyAverix Finance app for the latest dividend data.

What sector is CONTEXT THERAPEUT.DL-001 in?

CONTEXT THERAPEUT.DL-001 (6K9) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 6K9 listed on?

6K9 is listed on F.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)